PRAME and cervical cancer: Cervical cancer is responsible for 570 000 cancer cases worldwide, ranking fourth in incidence in 2018.24 A study showed that overexpression of PRAME in HeLa cervical cancer cells leads to an apparent change in morphology.32 Concomitantly, PRAME‐transfected HeLa cells show cytoplasmic vacuolization and blebbing.